Liyan Miao

728 total citations
26 papers, 560 citations indexed

About

Liyan Miao is a scholar working on Molecular Biology, Surgery and Pharmacology. According to data from OpenAlex, Liyan Miao has authored 26 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Pharmacology. Recurrent topics in Liyan Miao's work include Renal Transplantation Outcomes and Treatments (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Liyan Miao is often cited by papers focused on Renal Transplantation Outcomes and Treatments (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Liyan Miao collaborates with scholars based in China, United States and Hungary. Liyan Miao's co-authors include Congxin Huang, Ling Xue, Jingjing Zhang, Hua Zhang, Shuaibing Liu, Chenrong Huang, Chao Wang, Yifei Tu, Chen Pan and Hans van Dam and has published in prestigious journals such as Advanced Materials, Nature Communications and Frontiers in Pharmacology.

In The Last Decade

Liyan Miao

25 papers receiving 557 citations

Peers

Liyan Miao
Jung Yeon Ghee South Korea
Xiaojun Cai China
Kayoko Kojima Japan
Muhammad Imtiaz Ashraf Germany
Andrew Cameron United States
Juthipong Benjanuwattra United States
Takayuki Tanabe Japan
Jing Ren China
Ziwen Lu China
Yong-Min Choi South Korea
Jung Yeon Ghee South Korea
Liyan Miao
Citations per year, relative to Liyan Miao Liyan Miao (= 1×) peers Jung Yeon Ghee

Countries citing papers authored by Liyan Miao

Since Specialization
Citations

This map shows the geographic impact of Liyan Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Miao more than expected).

Fields of papers citing papers by Liyan Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyan Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Miao. The network helps show where Liyan Miao may publish in the future.

Co-authorship network of co-authors of Liyan Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Liyan Miao. A scholar is included among the top collaborators of Liyan Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyan Miao. Liyan Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Menghua, Zhiyao Chen, Xiaoxue Liu, Xiaojun Zhou, & Liyan Miao. (2025). Study of genetic polymorphisms and steady-state trough concentrations of imatinib and its active metabolite in predicting efficacy in gastrointestinal stromal tumors. Frontiers in Pharmacology. 16. 1604619–1604619.
2.
Zhang, Miaomiao, et al.. (2025). Encapsulation of doxorubicin in magnesium acetate liposomes as a pH-sensitive drug carrier for tumor therapy. iScience. 28(9). 113336–113336. 1 indexed citations
3.
Zheng, Meng, Chao Wang, Yicong Bian, et al.. (2024). Human dose-escalation study of PET imaging CD8+ T-cell infiltration in solid malignancies with [68Ga]Ga -NODAGA-SNA006. European Journal of Nuclear Medicine and Molecular Imaging. 52(4). 1332–1344. 2 indexed citations
4.
Xue, Ling, Rajeev K. Singla, Sonia Arrasate, et al.. (2024). Warfarin–A natural anticoagulant: A review of research trends for precision medication. Phytomedicine. 128. 155479–155479. 9 indexed citations
5.
Zheng, Meng, Fengqing Fu, Kaijie Zhang, et al.. (2023). Radioimmunotherapy Targeting B7-H3 in situ glioma models enhanced antitumor efficacy by Reconstructing the tumor microenvironment. International Journal of Biological Sciences. 19(13). 4278–4290. 7 indexed citations
6.
7.
8.
Wang, Yuping, et al.. (2022). Propofol rescues LPS-induced toxicity in HRT-8/SVneo cells via miR-216a-5p/TLR4 axis. Archives of Gynecology and Obstetrics. 305(4). 1055–1067. 3 indexed citations
9.
Xie, Feng, Xiaoxue Zhou, Peng Su, et al.. (2022). Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling. Nature Communications. 13(1). 4461–4461. 102 indexed citations
10.
Wang, Yan, Chao Wang, Shibiao Sang, et al.. (2022). Pilot study of a novel nanobody 68 Ga-NODAGA-SNA006 for instant PET imaging of CD8+ T cells. European Journal of Nuclear Medicine and Molecular Imaging. 49(13). 4394–4405. 26 indexed citations
11.
Zhou, Weiyan, Xiaoxue Liu, Zhenni Liu, et al.. (2022). Therapeutic drug monitoring status of four common antibiotics: vancomycin, meropenem, linezolid and teicoplanin. Scandinavian Journal of Clinical and Laboratory Investigation. 82(7-8). 556–562. 2 indexed citations
12.
Bian, Yicong, Sheng Ma, Linsheng Liu, et al.. (2022). Adenosine triphosphate-based tumor chemosensitivity assay may predict the clinical outcomes of gastric cancer patients receiving taxane-based post-operative adjuvant chemotherapy. Chinese Medical Journal. 135(11). 1383–1385. 1 indexed citations
13.
Wang, Yan, Haiqing Ni, Shuaixiang Zhou, et al.. (2020). Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity. Cancer Immunology Immunotherapy. 70(2). 365–376. 87 indexed citations
14.
Chen, Yanqing, et al.. (2015). Dexmedetomidine Ameliorate CLP‐Induced Rat Intestinal Injury via Inhibition of Inflammation. Mediators of Inflammation. 2015(1). 918361–918361. 41 indexed citations
15.
Gao, Jie, Haipeng Wang, Hua Zhang, et al.. (2014). The effects of CES1A2 A(−816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease. Pharmacogenetics and Genomics. 24(4). 204–210. 31 indexed citations
16.
Tao, Zhuo-Ying, et al.. (2011). The Antinociceptive Efficacy of HWTX-I Epidurally Administered in Rheumatoid Arthritis Rats. International Journal of Sports Medicine. 32(11). 869–874. 7 indexed citations
17.
Xue, Ling, et al.. (2011). Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in Healthy Chinese Volunteers. Pharmacology. 88(5-6). 288–294. 17 indexed citations
18.
Miao, Liyan, et al.. (2007). Association study of ABCB1 and CYP3A5 gene polymorphisms with sirolimus trough concentration and dose requirements in Chinese renal transplant recipients. Biopharmaceutics & Drug Disposition. 29(1). 1–5. 56 indexed citations
19.
Zubkov, Alexander Y., Liyan Miao, & John H. Zhang. (2004). Signal Transduction of ET-1 in Contraction of Cerebral Arteries. Journal of Cardiovascular Pharmacology. 44(Supplement 1). S24–S26. 12 indexed citations
20.
Guan, Yong‐Yuan, et al.. (1996). Effects of Rb1 from thePanax notoginseng saponins on arrhythmia and Ca2+ movement in rat heart cells. Drug Development Research. 39(2). 179–183. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jung Yeon Ghee Breakdown of academic impact, for papers by Xiaojun Cai Breakdown of academic impact, for papers by Kayoko Kojima Breakdown of academic impact, for papers by Muhammad Imtiaz Ashraf Breakdown of academic impact, for papers by Andrew Cameron Breakdown of academic impact, for papers by Juthipong Benjanuwattra Breakdown of academic impact, for papers by Takayuki Tanabe Breakdown of academic impact, for papers by Jing Ren Breakdown of academic impact, for papers by Ziwen Lu Breakdown of academic impact, for papers by Yong-Min Choi
Rankless by CCL
2026